No evidence of y250x transferrin receptor type 2 mutation in patients with porphyria cutanea tarda: A Study of 38 Cases [6]

Dermatology

Volumn 204, Issue 2, 2002, Pages 158-159

  Dereure, O ^a,b   Esculier, C ^a   Aguilar Martinez, P ^a   Dessis, D ^a   Guillot, B ^a   Guilhou, J J ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b HÔPITAL SAINT ELOI   (France)

Author keywords

Haemochromatosis; Iron overload; Porphyria cutanea tarda; Transferrin receptor

Indexed keywords

TRANSFERRIN RECEPTOR; UROPORPHYRINOGEN DECARBOXYLASE;

ADULT; CHROMOSOME 1Q; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; EXON; FEMALE; FERRITIN BLOOD LEVEL; GENE; GENE MUTATION; GENETIC CODE; GENETIC HETEROGENEITY; HEMOCHROMATOSIS; HFE GENE; HUMAN; HUMAN CELL; IRON METABOLISM; IRON OVERLOAD; IRON TRANSPORT; LETTER; LEUKOCYTE; MALE; PATHOGENESIS; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; RESTRICTION FRAGMENT; SEX RATIO;

FEMALE; HUMANS; IRON OVERLOAD; MALE; MIDDLE AGED; MUTATION; PORPHYRIA CUTANEA TARDA; RECEPTORS, TRANSFERRIN;

EID: 0036213785     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051842     Document Type: Letter

References (5)

1. Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in North America
2. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda
3. Hemochromatosis gene and other factors contributing to the pathogenesis of porphyria cutanea tarda
4. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22
5. HFE mutations and transferrin-receptor polymorphism analysis in porphyria cutanea tarda: A prospective analysis of 36 cases from southern France